163 related articles for article (PubMed ID: 37796419)
21. Fertility Preservation Through Oocyte Cryopreservation in a Patient with Ovarian Dysgerminocarcinoma: A Case Report.
Brezina PR; Ding J; Ke RW; Klosky JL; Tillmanns TD
J Reprod Med; 2015; 60(9-10):441-4. PubMed ID: 26592073
[TBL] [Abstract][Full Text] [Related]
22. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
[TBL] [Abstract][Full Text] [Related]
23. Disappearance of human chorionic gonadotropin and resumption of ovulation following abortion.
Marrs RP; Kletzky OA; Howard WF; Mishell DR
Am J Obstet Gynecol; 1979 Nov; 135(6):731-6. PubMed ID: 495673
[TBL] [Abstract][Full Text] [Related]
24. Fertility Preservation Decisions Among Newly Diagnosed Oncology Patients: A Single-Center Experience.
Nurudeen SK; Douglas NC; Mahany EL; Sauer MV; Choi JM
Am J Clin Oncol; 2016 Apr; 39(2):154-9. PubMed ID: 24441581
[TBL] [Abstract][Full Text] [Related]
25. Specific protocols of controlled ovarian stimulation for oocyte cryopreservation in breast cancer patients.
Cavagna F; Pontes A; Cavagna M; Dzik A; Donadio NF; Portela R; Nagai MT; Gebrim LH
Curr Oncol; 2018 Dec; 25(6):e527-e532. PubMed ID: 30607119
[TBL] [Abstract][Full Text] [Related]
26. Oocyte cryopreservation for fertility preservation in women with cancer.
Domingo J; Garcia-Velasco JA
Curr Opin Endocrinol Diabetes Obes; 2016 Dec; 23(6):465-469. PubMed ID: 27685935
[TBL] [Abstract][Full Text] [Related]
27. [Systematic proposal of fertility preservation by mature oocyte cryopreservation for recurrent benign ovarian tumors].
Dadoun Y; Azaïs H; Keller L; d'Orazio E; Collinet P; Decanter C
Gynecol Obstet Fertil Senol; 2017 Jun; 45(6):359-365. PubMed ID: 28506797
[TBL] [Abstract][Full Text] [Related]
28. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Fertility].
Raad J; Rolland L; Grynberg M; Courbiere B; Mathieu d'Argent E
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):330-336. PubMed ID: 32004782
[TBL] [Abstract][Full Text] [Related]
29. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation.
Cakmak H; Katz A; Cedars MI; Rosen MP
Fertil Steril; 2013 Dec; 100(6):1673-80. PubMed ID: 23987516
[TBL] [Abstract][Full Text] [Related]
30. [Fertility preserving methods in women with breast cancer before gonadotoxic therapy].
Halászová N; Crha I; Huser M; Weinberger V; Žáková J; Ješeta M; Lousová E; Filipinská E; Ventruba P
Ceska Gynekol; 2017; 82(4):287-292. PubMed ID: 28925272
[TBL] [Abstract][Full Text] [Related]
31. Fertility after breast cancer treatment.
Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568
[TBL] [Abstract][Full Text] [Related]
32. [Practical clinical aspects of oocyte vitrification for fertility preservation].
Courbiere B; Decanter C
Gynecol Obstet Fertil; 2014 Sep; 42(9):653-6. PubMed ID: 25164159
[TBL] [Abstract][Full Text] [Related]
33. The effect of aromatase inhibitor on controlled ovarian stimulation for oocyte cryopreservation in adolescent and young cancer patients.
Suzuki R; Horage-Okutsu Y; Kawahara T; Nakamura K; Shiraishi E; Iwahata H; Suzuki-Takahashi Y; Sugishita Y; Takae S; Suzuki N
J Obstet Gynaecol Res; 2023 Mar; 49(3):973-979. PubMed ID: 36606606
[TBL] [Abstract][Full Text] [Related]
34. Patients undergoing elective and oncofertility preservation respond similarly to controlled ovarian stimulation for fertility preservation.
Kira ATF; Hentschke MR; Vasconcelos NF; Colombo T; Trindade VD; Petracco A; Costa BEPD; Badalotti M
JBRA Assist Reprod; 2022 Aug; 26(3):407-411. PubMed ID: 35403417
[TBL] [Abstract][Full Text] [Related]
35. Ovarian tissue cryopreservation can be combined simultaneously with oocyte retrieval after controlled ovarian hyperstimulation.
Puy V; Dupeux M; Mayeur A; Grynberg M; Benoit A; Bendayan M; Zhegari F; Hesters L; Gallot V; Prevot S; Frydman N; Sonigo C
Hum Reprod; 2023 May; 38(5):860-871. PubMed ID: 36860186
[TBL] [Abstract][Full Text] [Related]
36. [Oncofertility and breast cancer].
Sonigo C; Grynberg M; Bringer S; Sermondade N
Bull Cancer; 2019 Dec; 106(12S1):S43-S52. PubMed ID: 32008738
[TBL] [Abstract][Full Text] [Related]
37. Fertility preservation in patients with gynaecologic malignancy: Response to ovarian stimulation and long-term outcomes.
Tsonis O; Kopeika J
Eur J Obstet Gynecol Reprod Biol; 2023 Nov; 290():93-100. PubMed ID: 37757729
[TBL] [Abstract][Full Text] [Related]
38. Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: Comparison of random start and early follicular phase stimulation - cohort study.
Muteshi C; Child T; Ohuma E; Fatum M
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():10-14. PubMed ID: 30227359
[TBL] [Abstract][Full Text] [Related]
39. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
[TBL] [Abstract][Full Text] [Related]
40. A Real-Life Analysis of Reproductive Outcome after Fertility Preservation in Female Cancer Patients.
Hulsbosch S; Koskas M; Tomassetti C; De Sutter P; Wildiers H; Neven P; D'Hooghe T; Amant F
Gynecol Obstet Invest; 2018; 83(2):156-163. PubMed ID: 29050014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]